Evaluation of Sorrento Therapeutics' Natural Killer Cells for COVID-19 Treatment

Project: Other project

Project Details

StatusActive
Effective start/end date3/11/203/11/21

Funding

  • Sorrento Therapeutics Inc: $351,595.00